Coronavirus

Principal investigator Richard Becker, MD, director of the University of Cincinnati Heart, Lung and Vascular Institute discusses the phase 2 clinical trial for razuprotafib.

The country is split on certain strategies and a potential vaccine. Here's why the message needs to go from national to regional.

The test provides qualitative detection of nucleic acid from SARS-CoV-2 in oral saline rinse specimens, nasopharyngeal swab, and nasal swab specimens in a universal transport media, as well as nasal swabs collected in oral saline rinse.

Regeneron’s REGN-COV2 reduced the time to alleviate symptoms.

Brad Spellberg, MD, describes the inconsistent, impersonal messaging given to the public as cases begin to rise again.

A panel of pediatric infectious diseases experts recommends supportive care only for children with mild or moderate COVID-19 and suggests remdesivir therapy for those with severe illness requiring supplemental oxygen.

From acute kidney injury to children with ADHD, here's the latest research and discussions around the pandemic's effect on other specialties.

The study retrospectively observed more than 800 patients in the Maryland and Washington, D.C. area during March and April.

Stanford investigators suggest the findings could continually represent an accurate estimate of US antibody accrual.

Apeiron Biologics reports on a case study related to COVID-19 related pneumonia.

An interview with a Harvard-based researcher on troubling associations between RDW and hospitalized COVID-19 patients' mortality risks.

Novavax made the announcement late yesterday about their investigational vaccine, NVX-CoV2373.

Adults with confirmed COVID-19 were twice as likely as control participants to report having dined out at a restaurant in the 14 days prior to symptom onset.

New international analysis highlights successes—and shortcomings—among Pacific Asia and European regions who began to reopen their societies.

Dr. Rodney E. Rohde, clinical laboratory scientist, discusses campus reopening as well as his work on rabies eradication.

The EUA grants clinicians and caregivers capability to provide serologic assay results in person to potentially infected patients.

The Chinese government approves trial for Sinovac's vaccine in these patient populations.

In the second survey in a series, more respondents said they were wearing face coverings, less would get vaccinated, and there was a slight increase in their fears about the severity of the disease.

Is it still safe to take your child to get a vaccine during the pandemic? According to experts, there are safety measures in place for this critically important task.

J&J is evaluating both 1- and 2-dose regimens of the adenovirus vector investigational vaccine.

A small study is reporting very few adverse effects and low rates of COVID-19 transmission rates from mother to baby.

A small study in Italy suggests that children are less likely than adults to be asymptomatic spreaders of COVID-19.

Dr. Debra Goff describes the rush to "Just in Case" prescribing of antibiotics early in the COVID-19 pandemic, when less was known about the clinical course of the disease.

Rheumatologists are understandably concerned regarding immune suppressed patients amid the coronavirus (COVID-19) pandemic. What are the risk factors for hospitalization? And do drugs which act against inflammation complicate matters?

On Friday, new guidelines from CDC sought to show how the pandemic coronavirus (COVID-19) spreads. By Monday, those guidelines changed.

Dr. Shervin Molayem, DDS, continues our discussion on his recent paper The Mouth-COVID Connection: Il-6 Levels in Periodontal Disease — Potential Role in COVID-19-Related Respiratory Complications.

The country successfully managed thousands of mild cases among foreign construction workers at the height of the pandemic through an isolation facility. It may not be an applicable model, though.

A pediatric cardiologist discusses the specifics of a case study, the importance of adaptability, and how her healthcare system has developed treatment protocols in these cases.

Medical science needs to understand the disease more clearly in this understudied patient population.

What the AstraZeneca vaccine research pause meant for physician-patient discussion on vaccine candidate safety.